Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4

Molecular and Cellular Biology

Volumn 26, Issue 1, 2006, Pages 192-198

  Grier, Jason D ^a   Xiong, Shunbin ^a   Elizondo Fraire, Ana C ^a   Parant, John M ^a   Lozano, Guillermina ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MDM2; PROTEIN MDMX; PROTEIN P53; MDM2 PROTEIN, MOUSE; MDM4 PROTEIN, MOUSE; ONCOPROTEIN; UBIQUITIN PROTEIN LIGASE;

ALLELE; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; GENE DELETION; GENE OVEREXPRESSION; GENETIC RECOMBINATION; HEART DEVELOPMENT; HEART FAILURE; HEART MUSCLE CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; ANIMAL; CONGENITAL HEART MALFORMATION; CYTOLOGY; DRUG ANTAGONISM; EMBRYO DEVELOPMENT; GENETICS; HEART; LETHAL GENE; METABOLISM; PHYSIOLOGY; PRENATAL DEVELOPMENT;

ANIMALIA;

ALLELES; ANIMALS; APOPTOSIS; CELL PROLIFERATION; EMBRYO; EMBRYONIC DEVELOPMENT; GENE DELETION; GENES, LETHAL; HEART; HEART DEFECTS, CONGENITAL; MICE; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES;

EID: 33644772395     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.26.1.192-198.2006     Document Type: Article

References (34)

1. Agah, R., P. A. Frenkel, B. A. French, L. H. Michael, P. A. Overbeek, and M. D. Schneider. 1997. Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J. Clin. Investig. 100:169-179.
2. Bottger, V., A. Bottger, C. Garcia-Echeverria, Y. F. Ramos, A. J. van der Eb, A. G. Jochemsen, and D. P. Lane. 1999. Comparative study of the p53-mdm2 and p53-MDMX interfaces. Oncogene 18:189-199.
3. Chavez-Reyes, A., J. M. Parant, L. L. Amelse, R. M. de Oca Luna, S. J. Korsmeyer, and G. Lozano. 2003. Switching mechanisms of cell death in mdm2- and mdm4-null mice by deletion of p53 downstream targets. Cancer Res. 63:8664-8669.
4. Farley, F. W., P. Soriano, L. S. Steffen, and S. M. Dymecki. 2000. Widespread recombinase expression using FLPeR (Flipper) mice. Genesis 28:106-110.
5. Fernandez, E., Z. Siddiquee, and R. V. Shohet. 2001. Apoptosis and proliferation in the neonatal murine heart. Dev. Dyn. 221:302-310.
6. Fijnvandraat, A. C., A. C. van Ginneken, P. A. de Boer, J. M. Ruijter, V. M. Christoffels, A. F. Moorman, and R. H. Lekanne Deprez. 2003. Cardiomyocytes derived from embryonic stem cells resemble cardiomyocytes of the embryonic heart tube. Cardiovasc. Res. 58:399-409.
7. Finch, R. A., D. B. Donoviel, D. Potter, M. Shi, A. Fan, D. D. Freed, C. Wang, B. P. Zambrowicz, R. Ramirez-Solis, A. T. Sands, and N. Zhang. 2002. Mdmx is a negative regulator of p53 activity in vivo. Cancer Res. 62:3221-3225.
8. Gan, L., M. Xiang, L. Zhou, D. S. Wagner, W. H. Klein, and J. Nathans. 1996. POU domain factor Brn-3b is required for the development of a large set of retinal ganglion cells. Proc. Natl. Acad. Sci. USA 93:3920-3925.
9. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
10. Godley, L. A., J. B. Kopp, M. Eckhaus, J. J. Paglino, J. Owens, and H. E. Varmus. 1996. Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes Dev. 10:836-850.
11. Grier, J. D., W. Yan, and G. Lozano. 2002. Conditonal allele of mdm2 which encodes a p53 inhibitor. Genesis 32:145-147.
12. Gu, J., H. Kawai, L. Nie, H. Kitao, D. Wiederschain, A. G. Jochemsen, J. Parant, G. Lozano, and Z. M. Yuan. 2002. Mutual dependence of MDM2 and MDMX in their functional inactivation of p53. J. Biol. Chem. 277:19251-19254.
13. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387:296-299.
14. Hollstein, M., B. Shomer, M. Greenblatt, T. Soussi, E. Hovig, R. Montesano, and C. C. Harris. 1996. Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acid Res. 24:141-146.
15. Honda, R., H. Tanaka, and H. Yasuda. 1997. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:25-27.
16. Jacks, T., L. Remington, B. O. Williams, E. M. Schmitt, S. Halachmi, R. T. Bronson, and R. A. Weinberg. 1994. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4:1-7.
17. Jackson, M. W., and S. J. Berberich. 2000. MdmX protects p53 from Mdm2-mediated degradation. Mol. Cell. Biol. 20:1001-1007.
18. Jones, S. N., A. E. Roe, L. A. Donehower, and A. Bradley. 1995. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378:206-208.
19. Kim, K. K., M. H. Soonpaa, A. I. Daud, G. Y. Koh, J. S. Kim, and L. J. Field. 1994. Tumor suppressor gene expression during normal and pathologic myocardial growth. J. Biol. Chem. 269:22607-22613.
20. Kubbutat, M. H., S. N. Jones, and K. H. Vousden. 1997. Regulation of p53 stability by Mdm2. Nature 387:299-303.
21. Lyons, G. E., S. Schiaffino, D. Sassoon, P. Barton, and M. Buckingham. 1990. Developmental regulation of myosin gene expression in mouse cardiac muscle. J. Cell Biol. 111:2427-2436.
22. Marine, J. C., and A. G. Jochemsen. 2004. Mdmx and Mdm2: brothers in arms? Cell Cycle 3:900-904.
23. Migliorini, D., E. L. Denchi, D. Danovi, A. Jochemsen, M. Capillo, A. Gobbi, K. Helin, P. G. Pelicci, and J.-C. Marine. 2002. Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development. Mol. Cell. Biol. 22:5527-5538.
24. Migliorini, D., D. Danovi, E. Colombo, R. Carbone, P. G. Pelicci, and J. C. Marine. 2002. Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation. J. Biol. Chem. 277:7318-7323.
25. Montes de Oca Luna, R., D. S. Wagner, and G. Lozano. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378:203-206.
26. Nagy, A., M. Gertsenstein, K. Vintersten, and R. Behringer (ed.). 2003. Manipulating the mouse embryo: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
27. Ng, W. A., I. L. Grupp, A. Subramaniam, and J. Robbins. 1991. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ. Res. 68:1742-1750.
28. Parant, J., A. Chavez-Reyes, N. A. Little, W. Yan, V. Reinke, A. G. Jochemsen, and G. Lozano. 2001. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat. Genet. 29:92-95.
29. Rumyantsev, P. P. 1991. Growth and hyperplasia of cardiac muscle cells. Harwood Academic Press, New York, N.Y.
30. Sharp, D. A., S. A. Kratowicz, M. J. Sank, and D. L. George. 1999. Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein. J. Biol. Chem. 274:38189-38196.
31. Soriano, P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21:70-71.
32. Tanimura, S., S. Ohtsuka, K. Mitsui, K. Shirouzu, A. Yoshimura, and M. Ohtsubo. 1999. Mdm2 interacts with Mdmx through their RING finger domains. FEBS Lett. 447:5-9.
33. Tyner, S. D., S. Venkatachalam, J. Choi, S. Jones, N. Ghebranious, H. Igelmann, X. Lu, G. Soron, B. Cooper, C. Brayton, S. Hee Park, T. Thompson, G. Karsenty, A. Bradley, and L. A. Donehower. 2002. p53 mutant mice that display early ageing-associated phenotypes. Nature 415:45-53.
34. Vousden, K. H. 2000. p53: death star. Cell 103:691-694.